BE639532A - - Google Patents
Info
- Publication number
- BE639532A BE639532A BE639532DA BE639532A BE 639532 A BE639532 A BE 639532A BE 639532D A BE639532D A BE 639532DA BE 639532 A BE639532 A BE 639532A
- Authority
- BE
- Belgium
- Prior art keywords
- oil
- association
- formula
- water
- desc
- Prior art date
Links
- 239000003921 oil Substances 0.000 claims description 7
- 235000019198 oils Nutrition 0.000 claims description 7
- 208000002720 Malnutrition Diseases 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 235000012343 cottonseed oil Nutrition 0.000 claims description 3
- 239000002385 cottonseed oil Substances 0.000 claims description 3
- 239000008121 dextrose Substances 0.000 claims description 3
- 125000005456 glyceride group Chemical group 0.000 claims description 2
- 235000000112 undernutrition Nutrition 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 210000002969 Egg Yolk Anatomy 0.000 claims 1
- 241000536399 Tina Species 0.000 claims 1
- 235000013345 egg yolk Nutrition 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 101700075458 rol-3 Proteins 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 239000011732 tocopherol Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 description 15
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 4
- 229960004203 Carnitine Drugs 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 229960001518 levocarnitine Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- 210000004369 Blood Anatomy 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- -1 for example Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000002960 lipid emulsion Substances 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 241000144080 Alestes Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 239000005630 Diquat Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000007842 Glycine max Species 0.000 description 1
- 229960002897 Heparin Drugs 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 102100008701 TTN Human genes 0.000 description 1
- 101710023457 TTN Proteins 0.000 description 1
- 241000120020 Tela Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940087168 alpha Tocopherol Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE639532A true BE639532A (it) |
Family
ID=203903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE639532D BE639532A (it) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE639532A (it) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3810994A (en) * | 1972-06-01 | 1974-05-14 | Ethyl Corp | Method and composition for treating obesity |
| DE2921312A1 (de) * | 1978-05-25 | 1979-12-06 | Claudio Cavazza | Pharmazeutisches mittel und dessen verwendung bei einer vollstaendig parenteralen ernaehrung |
| DE3037479A1 (de) * | 1979-10-05 | 1981-05-21 | Sigma Tau S.p.A. Industrie Farmaceutiche Riunite, Roma | Pharmazeutische zusammensetzung zur parenteralen ernaehrung aus l-carnitin oder acyl-l-carnitinen |
| DE3026368A1 (de) * | 1980-07-11 | 1982-02-18 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion |
| DE3339052A1 (de) * | 1982-10-29 | 1984-05-03 | Sigma-Tau S.p.A. Industrie Farmaceutiche Riunite, 00144 Roma | Pharmazeutisches praeparat zur verbesserung der biochemischen und verhaltens-parameter bei senilitaet |
| EP0627161A1 (en) * | 1993-06-02 | 1994-12-07 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Use of L-carnitine and alkanoyl L-carnitines in the storage of blood for transfusions and stabilizing solutions containing them |
-
0
- BE BE639532D patent/BE639532A/fr unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3810994A (en) * | 1972-06-01 | 1974-05-14 | Ethyl Corp | Method and composition for treating obesity |
| DE2921312A1 (de) * | 1978-05-25 | 1979-12-06 | Claudio Cavazza | Pharmazeutisches mittel und dessen verwendung bei einer vollstaendig parenteralen ernaehrung |
| DE3037479A1 (de) * | 1979-10-05 | 1981-05-21 | Sigma Tau S.p.A. Industrie Farmaceutiche Riunite, Roma | Pharmazeutische zusammensetzung zur parenteralen ernaehrung aus l-carnitin oder acyl-l-carnitinen |
| DE3026368A1 (de) * | 1980-07-11 | 1982-02-18 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion |
| DE3339052A1 (de) * | 1982-10-29 | 1984-05-03 | Sigma-Tau S.p.A. Industrie Farmaceutiche Riunite, 00144 Roma | Pharmazeutisches praeparat zur verbesserung der biochemischen und verhaltens-parameter bei senilitaet |
| EP0627161A1 (en) * | 1993-06-02 | 1994-12-07 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Use of L-carnitine and alkanoyl L-carnitines in the storage of blood for transfusions and stabilizing solutions containing them |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5698582A (en) | Compositions containing taxane derivatives | |
| EP0138931B1 (fr) | Composition dermatologique et son procede de preparation | |
| EP0522936A1 (fr) | Nouvelles compositions à base de dérivés de la classe des taxanes | |
| EP0424282B1 (fr) | Préparation cosmétique de bronzage | |
| FR2934954A1 (fr) | Emulsion fluorescente de vert d'indocyanine | |
| FR2604906A1 (fr) | Collyre | |
| EP0514665A1 (fr) | Mélange antioxydant liposoluble | |
| FR2934955A1 (fr) | Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions | |
| EP1443940A1 (fr) | Composition pharmaceutique a base de progesterone micronisee, son procede de preparation et ses utilisations | |
| EP3273947B1 (fr) | Composition pour la sante oculaire | |
| BE639532A (it) | ||
| FR2914188A1 (fr) | Nouvelle composition a base d'oxime de cholest-4-en-3-one | |
| CN103976901A (zh) | 负载辅酶q10和茶多酚的微纳米载体及其制备和应用方法 | |
| FR2560523A1 (fr) | Solution ophtalmique contenant du pranoprofene et de l'acide borique | |
| EP0233100A1 (fr) | Composition pharmaceutique,contenant un anesthésique local et/ou un analgésique central encapsulé dans des multilamellaires liposomes | |
| EP0913147B1 (fr) | Système à base de dérivé d'acide phosphonique et de métabisulfite pour stabiliser l'acide ascorbique | |
| EP0302769B1 (fr) | Emulsion lipidique destinée à la nutrition parentérale ou entérale | |
| WO1996021462A1 (fr) | Compositions pharmaceutiques comprenant une superoxyde dismutase | |
| FR2609394A1 (fr) | Solution aqueuse contenant un acide quinolone carboxylique | |
| Cheikh et al. | Étude in vitro de l’effet antifalcémiant des globules rouges et de l’activité antioxydante d’extraits de la poudre de racines de Maytenus senegalensis Lam (Celestraceae) | |
| CN108853054A (zh) | 一种环肽修饰的藤黄酸纳米结构脂质载体及其制备方法 | |
| MX2014009523A (es) | Composicion inyectable que contiene fosfatidilcolina desprovista de desoxicolato de sodio y metodo de preparacion de la misma. | |
| WO2000076499A2 (fr) | Medicaments ophtalmologiques neuro-et retino-protecteurs | |
| EP0520865B1 (fr) | Utilisation de dérivés d'acide pour la fabrication d'un médicament pédiculicide | |
| CA2493074A1 (fr) | Elevation du taux d'heme oxygenase avec des derives de la rheine |